US loses measles elimination status amid worst outbreak since 1991 Infectious disease is now continually spreading after being eliminated for 26 years, with more than 5,400 US cases The Guardian - US · Nov 17
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout Bausch Health Companies Inc. (NYSE:BHC) on Tuesday agreed to indirectly acquire DURECT Corp (NASDAQ:DRRX), including a novel therapeutic molecule, larsucosterol. Benzinga · Jul 29, 2025
Hairdressers call for tax reform in ‘save our salons’ Westminster protest The British Hair Consortium wants VAT on labour costs to be cut from 20% to 10% in the Spring Statement. The Independent UK · Mar 17, 2025
Protesters in Bulgaria slam bill to ban LGBTQ+ 'propaganda' in schools Protesters rallied outside Bulgaria’s parliament on Thursday to denounce a controversial legal amendment adopted the day before that bans talk of LGBTQ+ and so-called "non-traditional sexual choices" in schools. Radio France Internationale · Aug 9, 2024
Bulgaria Parliament Bans LGBTQ 'Promotion' In Schools Bulgaria's parliament passed changes to its education law Wednesday, widening its scope to ban LGBTQ "propaganda" in schools in what rights groups slammed as discriminatory. International Business Times · Aug 8, 2024
This Bausch Health Companies Unusually Active Option Is a No-Brainer Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead. Barchart · Mar 28, 2024
3 Pharma Stocks to Buy for February Gains The pharmaceutical industry is thriving due to the growing demand for quality healthcare and high-quality drugs, a rapidly aging population, and the rise in chronic diseases. To capitalize on the industry’s growth prospects, investors could consider buying fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Bausch Health Companies (BHC), and ACADIA… StockNews.com · Feb 13, 2024
The king of the hill preparing for a gradual descent from the peak On an autumnal Sunday a few weeks ago at Loton Park, Scott Moran climbed out of a top-flight hillclimb car for perhaps the final time to end his career at the top of the sport. Though this is far from retirement for the Ludlow driver, it signalled the end of… Autosport · Nov 9, 2023
UK warns Afghans stuck in Pakistan hotels to hide indoors amid refugee crackdown Exclusive: Warning issued to families as Pakistan begins expulsion of thousands of Afghan refugees The Independent UK · Nov 2, 2023
Sunak forced to bring thousands of Afghans granted sanctuary in Britain to UK from Pakistan amid safety fears British diplomats warned ministers that Pakistan government would begin crackdown on Afghan refugees on 1 November The Independent UK · Oct 20, 2023
UK shame as Pakistani police storm hotel and arrest Afghans promised sanctuary in Britain Exclusive: British High Commission were forced to intervene to secure release of UK-bound Afghans – as ex-Army boss accuses government of ignoring allies The Independent UK · Sep 29, 2023
How a Summers British Hillclimb dream became reality Hillclimbing has always been a hotbed of design innovation, and a whole industry has grown around the construction of low-volume single-seater racing cars. Current British Hillclimb Championship contender Alex Summers has now joined the select band of drivers who have built their own car and it has taken seven years… Autosport · May 21, 2023
Cost of living crisis gets sticky for British Honey Company Business expects end of year results to ‘fall below’ market expectations due to economic pressures Evening Standard · Aug 26, 2022
VIRI: Enrollment Complete in FORTRESS Trial; Results Expected in September 2022… By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT Benzinga · May 17, 2022
Benzinga · May 10, 2022 Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook Bausch Health Companies Inc (NYSE:BHC) has reported Q1 revenues of $1.92 billion, down 5% Y/Y. Excluding the unfavorable impact of foreign exchange of $41 million and divestitures & discontinuations of $72 million, revenue was flat organically compared to Q1 FY21. Adjusted net income declined to $263 million from $370 million a year…
Benzinga · May 9, 2022 RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816 million; consensus $819 million).
StockNews.com · May 9, 2022 Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population. The stocks of quality healthcare companies Bausch Health (BHC), Teleflex (TFX), Abcam (ABCM), and Integra LifeSciences (IART) are currently trading near their…
Benzinga · May 6, 2022 Closely Watched Bausch + Lomb IPO Priced Below Expectations Bausch + Lomb Corp (NASDAQ:BLCO) has priced its initial public offering at $18/share, falling short of expectations as it became the first big company in months to try going public in a turbulent stock market, writes Wall Street Journal. Bausch Health Companies Inc (NYSE:BHC), the parent company, raised $630 million in the offering. According to…
StockNews.com · May 4, 2022 5 Undervalued Stocks to Scoop Up in May The market selloff caused by the difficult macroeconomic and geopolitical issues has led many quality stocks to now trade below their intrinsic values. Agilent Technologies (A), United Therapeutics (UTHR), Nissan Motor (NSANY), Bausch Health (BHC), and Encore Wire (WIRE) are examples. These names are currently trading at discounts to their…
Benzinga · Feb 23, 2022 Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View Bausch Health Companies Inc (NYSE: BHC) has reported
StockNews.com · Feb 3, 2022 4 Mid-Cap Pharmaceutical Stocks to Buy This Month Despite supply chain disruptions and labor shortages, the pharma industry is well-positioned to continue growing due to the increasing medical needs of an aging population and advancements in treating chronic diseases. Therefore, amid current market volatility, we believe it could be wise to scoop up shares of quality mid-cap pharmaceutical…